Loading ...Martin Shkreli, the CEO that hiked price of HIV treatment drug, arrested on securities fraud charges
Martin Shkreli, the CEO of an American drugs company who hiked the price of life-saving HIV-related drugs from $13.50 to $750, was reportedly arrested on securities fraud charges relating to a firm that he founded.
He was charged with illegally taking stock from Retrophin Inc., a biotechnology firm he started in 2011, and using it pay off debts from unrelated business dealings, Bloomberg said.
The Eastern District of New York department of the US Attorney’s Office did not immediately respond to requests for comment.
Shkreli was ousted from Retrophin in 2014 and sued by its board.
